查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1632683

全球兽用狂犬病疫苗市场：市场规模、份额、趋势分析（按应用和地区）、细分市场预测（2025-2030 年）

Rabies Veterinary Vaccines Market Size, Share & Trends Analysis Report By Application (Companion Animals, Livestock Animals, Wildlife Animals), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

兽医狂犬病疫苗市场的成长与趋势：

根据 Grand View Research 的新报告，到 2030 年全球兽用狂犬病疫苗市场规模预计将达到 11 亿美元。

预计 2025 年至 2030 年期间市场复合年增长率为 5.9%。推动市场发展的关键因素包括人们对通用感染疾病的认识不断提高、流浪动物疫苗接种率提高以及政府加大力度，力争到 2030 年消灭狂犬病。推动动物狂犬病疫苗接种市场的主要因素之一是对牲畜疫苗的认识和教育。核准用于牲畜的疫苗很多，包括灭活病毒载体产品、改良病毒载体产品、肌肉注射产品、皮下注射产品、1-3年免疫期产品和最低免疫年龄产品等。定期的公众教育、负责任的宠物饲养、定期的兽医治疗和疫苗接种以及持续的专业培训是狂犬病预防和控制的重要组成部分。透过普及狂犬病感染途径等知识，提高人们避免接触野生动物、对食用的野生动物接种狂犬病疫苗的意识，对遏制野生动物感染的蔓延有很大帮助。此外，疫苗接种改善了牲畜的整体健康状况，并降低了全因死亡率。

狂犬病是一种攻击中枢神经系统的致命疾病，一旦出现临床症状就无法有效治疗方法。据估计，全球用于防治犬狂犬病的花费为 860 万美元，占每年发生的约 6 万例狂犬病死亡病例的 98%。过去 50 年来，美国为消灭动物和人类的狂犬病做出了巨大努力。由于大规模动物疫苗接种方法的发展和自由放养限制的实施，感染狗源狂犬病的动物数量已从每年多达 10,000 例减少。儘管做出了这些努力，狂犬病仍然对公众健康构成重大威胁，仍然在美国野生动物保护区的浣熊、臭鼬和狐狸中流行。

在世界各地，新冠肺炎疫情正在扰乱基本卫生服务。倡导「同一个健康」策略的联合狂犬病论坛于2020年成立，旨在加速实现这一目标。全球狂犬病策略的关键组成部分包括社区参与、改善人类狂犬病疫苗的取得机会以及扩大犬类的大规模疫苗接种。狂犬病消除策略的进展可以作为衡量服务不足人口获得医疗保健公平性的指标，也可以作为「同一个健康」成功的早期指标。大规模犬类疫苗接种是全球消除狂犬病策略的核心，目标疫苗接种覆盖率达到70%。大多数受影响的国家都遇到了犬隻疫苗分发困难、数量减少和进口延迟等问题。这是因为狗疫苗最初并不在必需物品清单之中。即使在尚比亚等拥有本地生产能力的国家，由于预算限制，也不可能生产狗用疫苗。

狂犬病透过唾液传播，并透过被感染动物的咬伤传播。狂犬病可以透过猴子、狗、蝙蝠传播，偶尔也透过猫传播。印尼98%的狂犬病病例都是由疯狗咬伤引起的。根据美国国家医学图书馆 2021 年 12 月发表的一篇论文，过去十年中，全球动物狂犬病病例数量略有增加。 2017 年至 2018 年，泰国开展了一项研究，旨在描述动物狂犬病的特征，使用广义加性模型评估每月狂犬病发病率与可理解因素之间的关係，并估计狂犬病传播的地理风险区域。研究显示，狗是泰国最常见的感染狂犬病的动物种类。大多数受感染的狗都是家养的、放养的且未接种疫苗的狗。狂犬病感染集中度最高的是东北地区，其次是中部和南部地区。短期来看，自6月以来发病数逐渐增加，2018年1月以来发病数明显增加。这些狂犬病流行国家正在采取强有力的措施，例如针对犬类的大规模疫苗接种计划、针对野生动物诱饵的狂犬病疫苗接种宣传活动以及强制对宠物进行狂犬病疫苗接种，预计将促进市场增长。

兽医狂犬病疫苗市场报告重点

  • 由于多个国家强制实施宠物狂犬病疫苗接种制度、主要实施大规模犬类疫苗接种计划以及犬类拥有收益占有率大幅上升，预计伴同性动物领域将在 2024 年占据最大的收入份额。
  • 由于已开发地区野生动物狂犬病疫苗接种宣传活动的加强，预计预测期内野生动物部门的复合年增长率将达到 4%。
  • 预计北美在预测期内仍将保持领先地位。这是因为该地区的人均兽医护理支出高且宠物拥有率高。美国几乎每个州都要求宠物定期接种狂犬病疫苗，以期在不久的将来实现消灭狂犬病的目标。

目录

第一章 分析方法及范围

第 2 章执行摘要

第 3 章 兽医狂犬病疫苗市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 兽医狂犬病疫苗市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL 分析
  • 法律规范
  • 定价分析
  • COVID-19影响分析

第 4 章 兽医狂犬病疫苗市场：按应用进行的估计和趋势分析

  • 细分仪表板
  • 兽医狂犬病疫苗市场：按应用进行趋势分析
  • 兽用狂犬病疫苗的应用前景
  • 市场规模预测及趋势分析（2018-2030年）
  • 伴同性动物
  • 家畜
  • 野生动物

第 5 章 兽医狂犬病疫苗市场：按分销管道进行的估计和趋势分析

  • 细分仪表板
  • 兽医狂犬病疫苗市场：按通路的波动分析
  • 兽用狂犬病疫苗分销通路前景
  • 市场规模预测及趋势分析（2018-2030年）
  • 零售
  • 电子商务
  • 医院/诊所药房

第 6 章：兽用狂犬病疫苗市场：按地区分類的估计和趋势分析

  • 区域控制面板
  • 市场规模预测及趋势分析（2018-2030年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲国家
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特
    • 其他中东和非洲地区

第七章 竞争格局

  • 公司分类
  • 主要市场参与企业的最新趋势和影响分析
  • 市场占有率分析（按公司划分）（2024 年）
  • 公司概况
    • Boehringer Ingelheim International GmbH
    • Zoetis Services LLC
    • Indian Immunologicals Ltd.
    • Merck & Co., Inc.
    • Virbac
    • BiogenesisBago
    • Elanco
    • Ceva
    • BroadChem Philippines Biopharma Corporation
  • 战略地图
    • 企业合併与收购 (M&A)
    • 伙伴关係和合作
    • 扩张
    • 其他的
  • 其他主要企业名单
Product Code: GVR-4-68040-011-9

Rabies Veterinary Vaccines Market Growth & Trends:

The global rabies veterinary vaccines market size is expected to reach USD 1.10 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.9% from 2025 to 2030. The key factors driving the market include an increase in zoonotic disease awareness, boosting stray animal immunization coverage, and growing number of government initiatives with the motive of eradicating rabies by 2030. One of the main drivers propelling the market for animal rabies vaccinations is domestic animal vaccine awareness and education. There are numerous vaccines approved for use in domestic animal species, which include inactivated and modified-live virus vector products, products for IM and SC injection, products with immunization durations ranging from 1 to 3 years, and products with a range of minimum vaccination ages. Regular public education, responsible pet ownership, routine veterinary treatment and vaccinations, and continuous professional training are crucial elements of rabies prevention and control. By spreading knowledge about rabies transmission channels, the necessity of avoiding contact with wildlife and vaccinating wildlife with bait rabies vaccines are widely initiated, which greatly helps in reducing the spread of the disease from wildlife sources. Additionally, the vaccination improves domestic animals' general health and is linked to a decline in all-cause mortality rates.

Rabies is a deadly disease that attacks the central nervous system and has no effective treatment once clinical signs appear. It is estimated that 8.6 million dollars are spent globally on canine rabies, which is responsible for 98% of approximately 60,000 total rabies deaths that occur each year. The U.S. has made enormous efforts over the past 50 years to eradicate rabies in both animal and human populations. The number of animals infected with canine-mediated rabies has decreased from up to 10,000 cases per year because of the development of mass animal vaccination procedures and the enforcement of leash restrictions. Despite these developments, rabies continues to pose a major threat to public health and is still prevalent in raccoons, skunks, and foxes in wildlife reservoirs throughout the U.S.

All around the world, the COVID-19 pandemic has disrupted crucial health services. The United Against Rabies Forum, which advocates a 'One Health' strategy, was established in 2020 to hasten the achievement of this objective. The main components of the global rabies strategy include community involvement, better access to human rabies vaccines, and expanded mass dog vaccination. The advancement of rabies eradication strategies can be used as a marker for the equity of healthcare access in underserved populations and as an early indicator for the successful implementation of 'One Health'. The core element of the global rabies elimination strategy is mass dog vaccination, with a 70% coverage rate as the goal. The majority of endemic nations saw difficulties with distribution, volume reductions, and importation delays for dog vaccines. This was because dog vaccines initially did not fit within the category of necessary items. Budget restrictions prevented the production of dog vaccines even in countries such as Zambia where they are made locally.

Rabies is spread through saliva, which means the infection can be transmitted through infected animal bites. Rabies can be transmitted by monkeys, dogs, bats, or, in some cases, cats. 98% of rabies cases in Indonesia are caused by rabid dog bites. According to an article published in December 2021, by the National Library of Medicine over the past 10 years, there has been a slight increase in the number of animal rabies cases globally. In Thailand, a study was conducted between 2017 and 2018 to identify the characteristics of animal rabies, assess the relationship between monthly rabies incidence and understandable factors using generalized additive models, and estimate the geographical risk areas for rabies spread. According to the study, dogs are the most common species in Thailand that are infected by rabies. The majority of the infected dogs were owned, roaming freely, and were not vaccinated. The northeast region of the country has the highest concentrations of rabies cases, followed by the middle and southern regions. In the short term, the number of cases increased gradually after June and significantly from January in 2018. Such rabies-endemic countries are taking strong measures such as dog mass vaccination programs, wildlife bait rabies vaccination campaigns, and mandatory pet rabies vaccinations among others, which are anticipated to fuel the growth of the market.

Rabies Veterinary Vaccines Market Report Highlights:

  • The companion animals segment held the largest revenue share in 2024 owing to the mandatory pet rabies vaccinations regulated in several countries, largely conducted mass dog vaccination programs, and significantly rising dog ownership rates
  • The wildlife animals segment is anticipated to expand at the fastest CAGR of 4% over the forecast period owing to the rising wildlife rabies vaccination campaigns in developed regions
  • North America is expected to maintain its lead over the forecast period. This is due to the region's high per capita animal healthcare spending and a large number of pet ownership rates. Almost every state in the U.S. mandates regular rabies vaccination for pets with the mission of eradicating rabies in the near future

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Vaccine Type
    • 1.2.3. Disease type
    • 1.2.4. Route of Administration
    • 1.2.5. Distribution Channel
    • 1.2.6. Regional Scope
    • 1.2.7. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Rabies Veterinary VaccinesVariables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising animal rabies vaccination coverage in developing countries
      • 3.2.1.2. Increasing concerns over zoonotic diseases
      • 3.2.1.3. Implementation of mass dog vaccination campaigns in various countries
      • 3.2.1.4. Initiatives by market participants
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Limited access to veterinary services in under developed countries
  • 3.3. Rabies Veterinary VaccinesAnalysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape
      • 3.3.2.7. Estimated Animal Population by key Species, key Country, 2018-2024
  • 3.4. Regulatory Framework
  • 3.5. Pricing Analysis
  • 3.6. COVID-19 impact Analysis

Chapter 4. Rabies Veterinary Vaccines market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Rabies Veterinary Vaccines market: Application Movement Analysis
  • 4.3. Rabies Veterinary Vaccinesby Application Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Companion Animals
    • 4.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.6. Livestock Animals
    • 4.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.7. Wildlife Animals
    • 4.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5. Rabies Veterinary Vaccines market: Distribution Channel Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Rabies Veterinary Vaccines market: Distribution Channel Movement Analysis
  • 5.3. Rabies Veterinary Vaccinesby Distribution Channel Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Retail
    • 5.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.6. E-Commerce
    • 5.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.7. Hospital/Clinic Pharmacies
    • 5.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6. Rabies Veterinary Vaccines market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. U.S. market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Canada market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Mexico market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. UK market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Germany market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. France market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Italy market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Spain market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Sweden market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.4.7. Denmark
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Denmark market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Norway market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.4.9. Rest of Europe
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Rest of Europe market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Japan market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. China market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. India market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Australia market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. South Korea market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Thailand market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.5.7. Rest of Asia-Pacific
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Rest of Asia-Pacific market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Brazil market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Argentina market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.6.3. Rest of LA
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Rest of LA market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. South Africa market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Saudi Arabia market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. UAE market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Kuwait market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.7.5. Rest of MEA
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Rest of MEA market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Recent Developments & Impact Analysis by Key Market Participants
  • 7.3. Company Market Share Analysis, 2024
  • 7.4. Company overview
    • 7.4.1. Boehringer Ingelheim International GmbH
      • 7.4.1.1. Company Overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Zoetis Services LLC
      • 7.4.2.1. Company Overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Indian Immunologicals Ltd.
      • 7.4.3.1. Company Overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Merck & Co., Inc.
      • 7.4.4.1. Company Overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Virbac
      • 7.4.5.1. Company Overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. BiogenesisBago
      • 7.4.6.1. Company Overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Elanco
      • 7.4.7.1. Company Overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Ceva
      • 7.4.8.1. Company Overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. BroadChem Philippines Biopharma Corporation
      • 7.4.9.1. Company Overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
  • 7.5. Strategy Mapping
    • 7.5.1. Mergers & Acquisitions
    • 7.5.2. Partnerships & Collaborations
    • 7.5.3. Expansions
    • 7.5.4. Others
  • 7.6. List of Other Key Players

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 4. Global Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 5. Global Rabies Veterinary Vaccines market, by Region, 2018 - 2030 (USD Million)
  • Table 6. North America Rabies Veterinary Vaccines market, by Country, 2018 - 2030 (USD Million)
  • Table 7. North America Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 8. North America Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 9. U.S. Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 10. U.S. Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 11. Canada Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 12. Canada Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13. Mexico Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 14. Mexico Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 15. Europe Rabies Veterinary Vaccines market, by Country, 2018 - 2030 (USD Million)
  • Table 16. Europe Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 17. Europe Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 18. UK Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 19. UK Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 20. Germany Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 21. Germany Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 22. France Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 23. France Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 24. Italy Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 25. Italy Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 26. Spain Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 27. Spain Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 28. Sweden Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 29. Sweden Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 30. Denmark Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 31. Denmark Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 32. Norway Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 33. Norway Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 34. Rest of Europe Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 35. Rest of Europe Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 36. Asia Pacific Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 37. Asia Pacific Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 38. Japan Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 39. Japan Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 40. China Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 41. China Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 42. India Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 43. India Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 44. Australia Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 45. Australia Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 46. South Korea Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 47. South Korea Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 48. Thailand Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 49. Thailand Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 50. Rest of Asia Pacific Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 51. Rest of Asia Pacific Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 52. Latin America Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 53. Latin America Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 54. Brazil Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 55. Brazil Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 56. Argentina Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 57. Argentina Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 58. Rest of LA Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 59. Rest of LA Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 60. Middle East and Africa Rabies Veterinary Vaccines market, by Country, 2018 - 2030 (USD Million)
  • Table 61. Middle East and Africa Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 62. Middle East and Africa Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 63. South Africa Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 64. South Africa Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 65. Saudi Arabia Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 66. Saudi Arabia Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 67. UAE Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 68. UAE Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 69. Kuwait Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 70. Kuwait Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 71. Rest of MEA Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 72. Rest of MEA Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Rabies Veterinary Vaccines market, Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Rabies Veterinary Vaccines market, for Application, 2018 - 2030 (USD Million)
  • Fig. 15 Global Rabies Veterinary Vaccines market, for Companion Animals, 2018 - 2030 (USD Million)
  • Fig. 16 Global Rabies Veterinary Vaccines market, for Livestock Animals, 2018 - 2030 (USD Million)
  • Fig. 17 Global Rabies Veterinary Vaccines market, for Wildlife Animals, 2018 - 2030 (USD Million)
  • Fig. 18 Global Rabies Veterinary Vaccines market, for Distribution Channel, 2018 - 2030 (USD Million)
  • Fig. 19 Global Rabies Veterinary Vaccines market, for Retail, 2018 - 2030 (USD Million)
  • Fig. 20 Global Rabies Veterinary Vaccines market, for E-Commerce, 2018 - 2030 (USD Million)
  • Fig. 21 Global Rabies Veterinary Vaccines market, for Hospital/Clinic Pharmacies, 2018 - 2030 (USD Million)
  • Fig. 22 Regional Outlook, 2024 & 2030
  • Fig. 23 North America Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 24 US Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 25 Canada Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 26 Mexico Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 27 Europe Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 28 UK Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 29 Germany Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 30 France Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 31 Italy Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 32 Spain Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 33 Sweden Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 34 Denmark Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 35 Norway Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 36 Rest of Europe Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 37 Asia Pacific Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 38 Japan Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 39 China Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 40 India Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 41 Australia Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 42 South Korea Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 43 Thailand Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 44 Rest of Asia Pacific Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 47 Argentina Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 48 Rest of LA Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 49 Middle East and Africa Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 52 UAE Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 54 Rest of MEA Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)